Human papillomavirus (HPV) causes about 6 800 new infections and 3 700 deaths from cervical cancer every year in South Africa. Cervical cancer is the most common cancer in women in this country with the age-standardised incidence rate of 30 per 100 000 per year (Mqoqi et al, 2004).
The policy brief asks whether a cervical cancer prevention programme that includes an HPV vaccine is more cost effective than theĀ current strategy of screening alone.